Tony Sabin

A statistician's perspective on biomarkers in drug development

C. Harbron, P. Delmar, T. Smart, 2011, Pharmaceutical statistics.

Assessing End of Phase 2 Decision Criteria

M. Parmar, A. Copas, J. Matcham, 2015 .

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Francisco Bonachela Capdevila, I. Bruce, Jane Worthington, 2022, Scientific Data.

A Quantitative Process for Enhancing End of Phase 2 Decisions

Andrew Copas, Tony Sabin, James Matcham, 2014, Statistics in biopharmaceutical research.

bcrm: Bayesian Continual Reassessment Method Designs for Phase I Dose-Finding Trials

Michael J. Sweeting, Tony Sabin, Adrian Mander, 2013 .